MedTrace Logo

Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects

NCT02609061 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2015-11-20

No results posted yet for this study

Summary

The present study was designed to evaluate the combined efficacy of PRF and 1% ALN in the treatment of mandibular degree II furcation defects when compared with PRF and open flap debridement (OFD) alone.

Conditions

  • Furcation Defects

Interventions

PROCEDURE

Open flap debridement (OFD)

Open flap debridement (OFD) alone

PROCEDURE

OFD with Platelet rich fibrin (PRF)

Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement

PROCEDURE

OFD with Platelet rich fibrin (PRF)+1% Alendronate (Drug) in gel form

Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate gel placement

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609061 on ClinicalTrials.gov